289 related articles for article (PubMed ID: 18098339)
21. Higher median levels of free beta-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group. Implication for first trimester combined screening for Down's syndrome in the Chinese population.
Leung TY; Spencer K; Leung TN; Fung TY; Lau TK
Fetal Diagn Ther; 2006; 21(1):140-3. PubMed ID: 16354992
[TBL] [Abstract][Full Text] [Related]
22. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
[TBL] [Abstract][Full Text] [Related]
23. Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A in twin pregnancies in the first trimester.
Niemimaa M; Suonpää M; Heinonen S; Seppälä M; Bloigu R; Ryynänen M
Prenat Diagn; 2002 Mar; 22(3):183-5. PubMed ID: 11920889
[TBL] [Abstract][Full Text] [Related]
24. Prediction of intrauterine growth restriction with customised estimated fetal weight centiles.
Owen P; Ogah J; Bachmann LM; Khan KS
BJOG; 2003 Apr; 110(4):411-5. PubMed ID: 12699804
[TBL] [Abstract][Full Text] [Related]
25. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
Christiansen M; Nørgaard-Pedersen B
Clin Genet; 2005 Jul; 68(1):35-9. PubMed ID: 15952984
[TBL] [Abstract][Full Text] [Related]
26. First and second-trimester biochemical markers of chromosomal anomalies and their relationship to maternal haemoglobin levels.
Cowans NJ; Spencer K
Prenat Diagn; 2005 Aug; 25(8):693-9. PubMed ID: 16050001
[TBL] [Abstract][Full Text] [Related]
27. Does a "vanishing twin" affect first-trimester biochemistry in Down syndrome risk assessment?
Chasen ST; Perni SC; Predanic M; Kalish RB; Chervenak FA
Am J Obstet Gynecol; 2006 Jul; 195(1):236-9. PubMed ID: 16626615
[TBL] [Abstract][Full Text] [Related]
28. Weight adjustment of serum markers in early first-trimester prenatal screening for Down syndrome.
Sørensen T; Larsen SO; Christiansen M
Prenat Diagn; 2005 Jun; 25(6):484-8. PubMed ID: 15966040
[TBL] [Abstract][Full Text] [Related]
29. A comparison between maternal serum free beta-human chorionic gonadotrophin and pregnancy-associated plasma protein A levels in first-trimester twin and singleton pregnancies.
Mashiach R; Orr-Urtreger A; Yaron Y
Fetal Diagn Ther; 2004; 19(2):174-7. PubMed ID: 14764965
[TBL] [Abstract][Full Text] [Related]
30. Maternal serum pregnancy-associated plasma protein A (PAPP-A) but not pregnancy-specific beta1-glycoprotein (SP1) is a useful second-trimester marker for fetal trisomy 18.
Bersinger NA; Leporrier N; Herrou M; Leymarie P
Prenat Diagn; 1999 Jun; 19(6):537-41. PubMed ID: 10416969
[TBL] [Abstract][Full Text] [Related]
31. Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery.
Morssink LP; Kornman LH; Hallahan TW; Kloosterman MD; Beekhuis JR; de Wolf BT; Mantingh A
Prenat Diagn; 1998 Feb; 18(2):147-52. PubMed ID: 9516016
[TBL] [Abstract][Full Text] [Related]
32. Predicting complications of pregnancy with first-trimester maternal serum free-betahCG, PAPP-A and inhibin-A.
Tul N; Pusenjak S; Osredkar J; Spencer K; Novak-Antolic Z
Prenat Diagn; 2003 Dec; 23(12):990-6. PubMed ID: 14663836
[TBL] [Abstract][Full Text] [Related]
33. Elevated maternal mid-trimester chorionic gonadotropin > or =4 MoM is associated with fetal cerebral blood flow redistribution.
Hershkovitz R; Erez O; Sheiner E; Landau D; Mankuta D; Mazor M
Acta Obstet Gynecol Scand; 2003 Jan; 82(1):22-7. PubMed ID: 12580835
[TBL] [Abstract][Full Text] [Related]
34. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia.
Laigaard J; Sørensen T; Placing S; Holck P; Fröhlich C; Wøjdemann KR; Sundberg K; Shalmi AC; Tabor A; Nørgaard-Pedersen B; Ottesen B; Christiansen M; Wewer UM
Obstet Gynecol; 2005 Jul; 106(1):144-9. PubMed ID: 15994630
[TBL] [Abstract][Full Text] [Related]
35. Frequency and clinical consequences of extremely high maternal serum PAPP-A levels.
Cuckle H; Arbuzova S; Spencer K; Crossley J; Barkai G; Krantz D; Muller F; Nikolenko M; Aitken D; Hallahan T; Macri J; Buchanan PD
Prenat Diagn; 2003 May; 23(5):385-8. PubMed ID: 12749035
[TBL] [Abstract][Full Text] [Related]
36. Maternal serum free beta-hCG and PAPP-A in fetal sex chromosome defects in the first trimester.
Spencer K; Tul N; Nicolaides KH
Prenat Diagn; 2000 May; 20(5):390-4. PubMed ID: 10820406
[TBL] [Abstract][Full Text] [Related]
37. Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol.
Markestad T; Bergsjø P; Aakvaag A; Lie RT; Jacobsen G; Hoffman HJ; Bakketeig LS
Acta Obstet Gynecol Scand Suppl; 1997; 165():50-5. PubMed ID: 9219457
[TBL] [Abstract][Full Text] [Related]
38. Association between first trimester maternal serum pregnancy associated plasma protein-A and adverse pregnancy outcome.
Kwik M; Morris J
Aust N Z J Obstet Gynaecol; 2003 Dec; 43(6):438-42. PubMed ID: 14712947
[TBL] [Abstract][Full Text] [Related]
39. First-trimester screening for fetal triploidy at 11 to 14 weeks: a role for fetal biometry.
Salomon LJ; Bernard JP; Nizard J; Ville Y
Prenat Diagn; 2005 Jun; 25(6):479-83. PubMed ID: 15966039
[TBL] [Abstract][Full Text] [Related]
40. The significance of crown-rump length measurement for predicting adverse pregnancy outcome of threatened abortion.
Reljic M
Ultrasound Obstet Gynecol; 2001 Jun; 17(6):510-2. PubMed ID: 11422973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
